Baby stroller and pram market in the US- Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2025 | Technavio

News, market analysis, investment scam prevention tips and more ✔️ Your source for latest asset management news and information. This magazine is crafted specifically for those who are interested in diving into the global asset management world. NEW YORK, April 23, 2021 /PRNewswire/ -- The baby stroller and pram market in the US is poised to grow by $ 95.38 mn during 2021-2025, progressing at a CAGR of almost 4% during the forecast period. Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour. Download FREE Sample Report The report on the baby stroller and pram market in the US provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis. The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by changing lifestyles and innovation and portfolio extension leading to premiumization of product and growing demand for baby strollers and prams that are compliant with safety regulations.The baby stroller and pram market in US analysis includes product segment, distribution channel segment, and geography landscape. This study identifies the increasing disposable income as one of the prime reasons driving the baby stroller and pram market in US growth during the next few years.This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.The baby stroller and pram market in the US covers the following areas:Baby stroller and pram market in US SizingBaby stroller and pram market in US ForecastBaby stroller and pram market in US Analysis Companies MentionedArtsana Spa Baby Trend Inc. Britax Bugaboo International BV Combi Corp. Dorel Industries Inc. Goodbaby International Holdings Ltd. Inglesina USA Inc. Newell Brands Inc. Nuna International BVRelated Reports on Consumer Discretionary Include:Automotive Audio Speakers Market by Application and Geography - Forecast and Analysis 2021-2025- The automotive audio speakers market has the potential to grow by USD 6.38 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 7.29%. Download FREE sample reportSpa Market by Type and Geography - Forecast and Analysis 2021-2025- The spa market has the potential to grow by USD 22.08 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 6.15%. Download FREE sample reportKey Topics Covered:Executive SummaryMarket Landscape Market ecosystem Value chain analysisMarket SizingMarket definition Market segment analysis Market size 2020 Market outlook: Forecast for 2020 - 2025Five Forces AnalysisFive forces summary Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market conditionMarket Segmentation by ProductMarket segments Comparison by Product Baby comfort stroller - Market size and forecast 2020-2025 Baby buggies - Market size and forecast 2020-2025 Baby comfort pram - Market size and forecast 2020-2025 Baby 3 wheeler stroller - Market size and forecast 2020-2025 Baby tandem stroller - Market size and forecast 2020-2025 Market opportunity by ProductMarket Segmentation by Distribution channelMarket segments Comparison by Distribution channel Offline - Market size and forecast 2020-2025 Online - Market size and forecast 2020-2025 Market opportunity by Distribution channelCustomer landscape Customer landscape Market drivers Market challenges Market trendsVendor LandscapeVendor landscape Landscape disruptionVendor AnalysisVendors covered Market positioning of vendors Artsana Spa Baby Trend Inc. Britax Bugaboo International BV Combi Corp. Dorel Industries Inc. Goodbaby International Holdings Ltd. Inglesina USA Inc. Newell Brands Inc. Nuna International BVAppendixScope of the report Currency conversion rates for US$ Research methodology List of abbreviationsTechnavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.Register for a free trial today and gain instant access to 17,000+ market research reports. Download FREE Sample Report About UsTechnavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: media@technavio.comWebsite: www.technavio.com/Report Link:https://www.technavio.com/report/baby-stroller-and-pram-market-in-us-industry-analysis View original content to download multimedia:https://www.prnewswire.com/news-releases/baby-stroller-and-pram-market-in-the-us--industry-analysis-market-trends-market-growth-opportunities-and-forecast-2025--technavio-301275710.htmlSOURCE Technavio To keep reading about Baby stroller and pram market in the US- Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2025 | Technavio, Click on the link. Seoul, Korea
http://dlvr.it/RyKWpj

Comments

Post a Comment

Popular posts from this blog

AstraZeneca Begins Phase I Trial Of AZD7442 Against COVID-19 – Quick Facts

Image
(RTTNews) - AstraZeneca Plc (AZN.L, AZN) said first participants have been dosed in a Phase I trial of AZD7442 for the prevention and treatment of COVID-19. The trial will evaluate the safety, tolerability and pharmacokinetics of AZD7442. It will include up to 48 healthy participants in the UK aged 18 to 55 years. AZD7442 is a combination of two monoclonal antibodies derived from convalescent patients with SARS-CoV-2 infection. Discovered by Vanderbilt University Medical Center and licensed to AstraZeneca in June 2020, the mAbs were optimised by AstraZeneca. Data readout from the trial is anticipated in the second half of 2020. To keep reading about AstraZeneca Begins Phase I Trial Of AZD7442 Against COVID-19 – Quick Facts, Click on the link. Seoul, Korea http://dlvr.it/RfHgSK
Read more

Coronavirus Hasn't Diminished Tech Stocks' Allure

Image
FYI: By Caitlin McCabe Caitlin McCabe The Wall Street Journal Biography caitlin.mccabe@wsj.com Updated April 20, 2020 6:14 pm ET The FANG trade hasn’t lost its bite. Big technology stocks are again charging to new heights and propelling the broader stock market, which is swiftly rebounding after a punishing selloff. The NYSE FANG+ index—which comprises Facebook Inc., FB -0.56% Amazon.com Inc., AMZN 0.78% Netflix Inc. NFLX 3.44% and Google parent Alphabet Inc., GOOG -1.30% along with Apple Inc., AAPL -2.08% Twitter Inc., Tesla Inc., TSLA -1.00% Nvidia Corp. NVDA -1.80% and the Chinese behemoths Alibaba Group Holding Ltd. and Baidu Inc. —is up 11% year-to-date after a dramatic rally last week. The four FANG stocks added $251 billion in market value last week, their biggest gain on record dating to Facebook’s 2012 initial public offering. The S&P 500, in comparison, is down 13% in 2020 but has r
Read more

Henlius Plans to File the NDA of Novel anti-PD-1 mAb HLX10 for the Treatment of MSI-H Solid Tumours, the Phase 2 Clinical Trial has Met the Primary Endpoint

News, market analysis, investment scam prevention tips and more ✔️ Your source for latest asset management news and information. This magazine is crafted specifically for those who are interested in diving into the global asset management world. SHANGHAI, March 28, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the Phase 2 study of its innovative PD-1 inhibitor HLX10 in patients with unresectable or metastatic microsatellite instability-high or mismatch repair-deficient (MSI-H/dMMR) solid tumors that fail to respond to the standard therapy has met the primary endpoint. Henlius plans to file a New Drug Application (NDA) to the National Drug Products Administration (NMPA) for the treatment of MSI-H solid tumours based on the results from the Phase 2 trial of HLX10, which will be presented at upcoming medical conferences. Professor Shukui Qin of No.81 Hospital of People's Liberation Army and Professor Jin Li of Shanghai East Hospital affiliated to Shang
Read more